Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)
Crossref DOI link: https://doi.org/10.1186/s13075-014-0467-3
Published Online: 2014-10-30
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kennedy, William P
Simon, J Abraham
Offutt, Carolyn
Horn, Priscilla
Herman, Ann
Townsend, Michael J
Tang, Meina T
Grogan, Jane L
Hsieh, Frank
Davis, John C
License valid from 2014-10-01